Systematic Review
Published on 16 Apr 2024
Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
in Multiple Sclerosis and Neuroimmunology
- 5,077 views
- 3 citations
Systematic Review
Published on 16 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 11 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 11 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 09 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Correction
Published on 08 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 05 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 05 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 04 Apr 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 27 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 27 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 26 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 26 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 26 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 25 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 21 Mar 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 21 Mar 2024
in Multiple Sclerosis and Neuroimmunology